普米克令舒联合特布他林雾化吸入对小儿喘息性支气管肺炎的疗效观察(1)
[摘要] 目的 探讨普米克令舒联合特布他林雾化吸入对小儿喘息性支气管肺炎的治疗效果。 方法 选择我院2016年2月～2017年2月收治的50例喘息性支气管肺炎患儿为观察对象，将患儿随机分为对照组和观察组两组，各25例。对照组患儿使用常规治疗，观察组患儿使用普米克令舒联合特布他林雾化吸入治疗，对比两组患儿的临床治疗效果。 结果 观察组患儿的体征消退、症状消退及住院时间均比对照组短，差异具有统计学意义(P<0.05)；观察组患儿的治疗有效率为96.0%高于对照组的72.0%，差异具有统计学意义(P<0.05)；治疗之后，观察组患儿的肺功能指标改善情况优于对照组，差异具有统计学意义(P<0.05)。 结论 使用普米克令舒联合特布他林雾化吸入在治疗小儿喘息性支气管肺炎中具有良好的效果，能够使患儿快速消除症状，并且缩短患儿的住院时间，提高患儿的肺功能，值得临床推广使用。
[关键词] 普米克令舒；特布他林雾化吸入；小儿喘息性支气管肺炎；肺功能改善
[中图分类号] R725.6 [文献标识码] B [文章编号] 1673-9701(2018)14-0055-03
[Abstract] Objective To study the therapeutic effect of pulmicort respules combined with terbutaline inhalation on pediatric asthmatic bronchial pneumonia. Methods 50 children with asthmatic bronchial pneumonia who were admitted in our hospital from February 2016 to February 2017 were selected as observation objects. The children were randomly divided into two groups including control group and observation group， with 25 cases in each group. The control group was treated with routine treatment. The observation group was treated with pulmicort combined with terbutaline inhalation. The clinical efficacy between the two groups of children was compared. Results The subsiding time of signs and symptoms， and length of hospital stay in the observation group were shorter than those in the control group. The difference was statistically significant(P<0.05).The treatment effective rate in the observation group was 96.0%， higher than that in the control group(72.0%).The difference of the data was statistically significant(P<0.05). After treatment， the improvement of the lung function index in the observation group was better than that in the control group， and the difference was statistically significant(P<0.05). Conclusion The use of pulmicort combined with terbutaline inhalation has a good effect in the treatment of children with asthmatic bronchial pneumonia， which can quickly eliminate symptoms in children，and shorten the hospitalization time of children， improve children's lung function， and it is worthy of clinical use.
[Key words] Pulmicort respules； Terbutaline inhalation； Pediatric asthmatic bronchial pneumonia； Improvement of lung function
喘息性支气管炎肺炎(Asthmatic bronchitis pneumonia，ABP)是以喘息为主要症状的急性呼吸系统性疾病，多發于3岁以下的小儿，主要发病原因为病毒感染，包括流感病毒、合胞病毒等[1-2]。在患儿病情不断发展的过程中容易出现细菌感染，如果没有对患儿进行及时的治疗，就会使患儿疾病转化为哮喘，严重威胁了患儿的身心健康[3-4]。目前在对喘息性支气管肺炎治疗的过程中，主要采取对症治疗，但是疗效并不显著。从此病症发病的基础进行分析，其治疗重点就使患儿的气道阻塞得到有效的解决，此方面最有优势的方法就是雾化吸入[5]。基于此，本研究选择我院收治的50例喘息性支气管肺炎患儿为对象，观察普米克令舒联合特布他林雾化吸入的治疗效果，现报道如下。, 百拇医药(江才华)
[关键词] 普米克令舒；特布他林雾化吸入；小儿喘息性支气管肺炎；肺功能改善
[中图分类号] R725.6 [文献标识码] B [文章编号] 1673-9701(2018)14-0055-03
[Abstract] Objective To study the therapeutic effect of pulmicort respules combined with terbutaline inhalation on pediatric asthmatic bronchial pneumonia. Methods 50 children with asthmatic bronchial pneumonia who were admitted in our hospital from February 2016 to February 2017 were selected as observation objects. The children were randomly divided into two groups including control group and observation group， with 25 cases in each group. The control group was treated with routine treatment. The observation group was treated with pulmicort combined with terbutaline inhalation. The clinical efficacy between the two groups of children was compared. Results The subsiding time of signs and symptoms， and length of hospital stay in the observation group were shorter than those in the control group. The difference was statistically significant(P<0.05).The treatment effective rate in the observation group was 96.0%， higher than that in the control group(72.0%).The difference of the data was statistically significant(P<0.05). After treatment， the improvement of the lung function index in the observation group was better than that in the control group， and the difference was statistically significant(P<0.05). Conclusion The use of pulmicort combined with terbutaline inhalation has a good effect in the treatment of children with asthmatic bronchial pneumonia， which can quickly eliminate symptoms in children，and shorten the hospitalization time of children， improve children's lung function， and it is worthy of clinical use.
[Key words] Pulmicort respules； Terbutaline inhalation； Pediatric asthmatic bronchial pneumonia； Improvement of lung function
喘息性支气管炎肺炎(Asthmatic bronchitis pneumonia，ABP)是以喘息为主要症状的急性呼吸系统性疾病，多發于3岁以下的小儿，主要发病原因为病毒感染，包括流感病毒、合胞病毒等[1-2]。在患儿病情不断发展的过程中容易出现细菌感染，如果没有对患儿进行及时的治疗，就会使患儿疾病转化为哮喘，严重威胁了患儿的身心健康[3-4]。目前在对喘息性支气管肺炎治疗的过程中，主要采取对症治疗，但是疗效并不显著。从此病症发病的基础进行分析，其治疗重点就使患儿的气道阻塞得到有效的解决，此方面最有优势的方法就是雾化吸入[5]。基于此，本研究选择我院收治的50例喘息性支气管肺炎患儿为对象，观察普米克令舒联合特布他林雾化吸入的治疗效果，现报道如下。, 百拇医药(江才华)